Literature DB >> 24202618

Inflammaging: should this term be suitable for age related macular degeneration too?

Carla Enrica Gallenga1, Francesco Parmeggiani, Ciro Costagliola, Adolfo Sebastiani, Pier Enrico Gallenga.   

Abstract

INTRODUCTION: Inflammaging is a phenomenon triggered by the conjunction of chronic repetitive and subclinical inflammation from external aggressors and internal inflammatory mechanisms due to the progressive degradation of systems such as the mitochondrial function. Age-related macular degeneration is the leading cause of blindness and visual impairment in patients older than 60 years in developed countries. DISCUSSION: Remarkable correlations have been documented between common or rare immunological/inflammatory gene polymorphisms and AMD, unequivocally indicating the involvement of inflammation and immune-mediated processes (complement activation) in the pathogenesis of this disease.
CONCLUSION: Altogether these factors also drive this pathologic condition under the general heading of "Inflammaging".

Entities:  

Mesh:

Year:  2013        PMID: 24202618     DOI: 10.1007/s00011-013-0684-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  18 in total

Review 1.  Inflamm-aging. An evolutionary perspective on immunosenescence.

Authors:  C Franceschi; M Bonafè; S Valensin; F Olivieri; M De Luca; E Ottaviani; G De Benedictis
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

Review 2.  Inflammaging (inflammation + aging): A driving force for human aging based on an evolutionarily antagonistic pleiotropy theory?

Authors:  Makoto Goto
Journal:  Biosci Trends       Date:  2008-12       Impact factor: 2.400

Review 3.  Early environments and the ecology of inflammation.

Authors:  Thomas W McDade
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

Review 4.  New insights into chronic inflammation-induced immunosuppression.

Authors:  Julia Kanterman; Moshe Sade-Feldman; Michal Baniyash
Journal:  Semin Cancer Biol       Date:  2012-02-24       Impact factor: 15.707

Review 5.  Age-associated chronic diseases require age-old medicine: role of chronic inflammation.

Authors:  Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Prev Med       Date:  2011-12-09       Impact factor: 4.018

6.  Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye.

Authors:  Tony Lin; Gregory Brett Walker; Khaliq Kurji; Edward Fang; Geoffrey Law; Shiv S Prasad; Luba Kojic; Sijia Cao; Valerie White; Jing Z Cui; Joanne A Matsubara
Journal:  Cytokine       Date:  2013-04-17       Impact factor: 3.861

Review 7.  The epidemiology of age-related macular degeneration.

Authors:  Ronald Klein; Tunde Peto; Alan Bird; Mylan R Vannewkirk
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

8.  Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Authors: 
Journal:  JAMA       Date:  2013-05-15       Impact factor: 56.272

9.  Is inflammaging an auto[innate]immunity subclinical syndrome?

Authors:  Sergio Giunta
Journal:  Immun Ageing       Date:  2006-12-16       Impact factor: 6.400

Review 10.  Mechanism of inflammation in age-related macular degeneration.

Authors:  Francesco Parmeggiani; Mario R Romano; Ciro Costagliola; Francesco Semeraro; Carlo Incorvaia; Sergio D'Angelo; Paolo Perri; Paolo De Palma; Katia De Nadai; Adolfo Sebastiani
Journal:  Mediators Inflamm       Date:  2012-11-07       Impact factor: 4.711

View more
  9 in total

1.  Age-Related Macular Degeneration: A Connection between Human Herpes Virus-6A-Induced CD46 Downregulation and Complement Activation?

Authors:  Walter Fierz
Journal:  Front Immunol       Date:  2017-10-17       Impact factor: 7.561

Review 2.  The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates.

Authors:  Claudio Franceschi; Paolo Garagnani; Cristina Morsiani; Maria Conte; Aurelia Santoro; Andrea Grignolio; Daniela Monti; Miriam Capri; Stefano Salvioli
Journal:  Front Med (Lausanne)       Date:  2018-03-12

3.  Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration.

Authors:  Jan Spindler; Souska Zandi; Isabel B Pfister; Christin Gerhardt; Justus G Garweg
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240

4.  Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration.

Authors:  Francesco Parmeggiani; Carla Enrica Gallenga; Ciro Costagliola; Francesco Semeraro; Mario R Romano; Roberto Dell'Omo; Andrea Russo; Katia De Nadai; Donato Gemmati; Sergio D'Angelo; Elena Bolletta; Francesco Saverio Sorrentino
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

5.  Apigenin and Ethaverine Hydrochloride Enhance Retinal Vascular Barrier In Vitro and In Vivo.

Authors:  Weiwei Jiang; Huan Chen; Zhengfu Tai; Tian Li; Ling Luo; Zongzhong Tong; Weiquan Zhu
Journal:  Transl Vis Sci Technol       Date:  2020-05-11       Impact factor: 3.283

6.  Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.

Authors:  Francesco Parmeggiani; Ciro Costagliola; Francesco Semeraro; Mario R Romano; Michele Rinaldi; Carla Enrica Gallenga; Maria Luisa Serino; Carlo Incorvaia; Sergio D'Angelo; Katia De Nadai; Roberto Dell'Omo; Andrea Russo; Donato Gemmati; Paolo Perri
Journal:  Int J Mol Sci       Date:  2015-08-20       Impact factor: 5.923

Review 7.  Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?

Authors:  Alasdair Warwick; Samir Khandhadia; Sarah Ennis; Andrew Lotery
Journal:  J Clin Med       Date:  2014-11-03       Impact factor: 4.241

Review 8.  Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.

Authors:  Francesco Parmeggiani; Francesco S Sorrentino; Mario R Romano; Ciro Costagliola; Francesco Semeraro; Carlo Incorvaia; Sergio D'Angelo; Paolo Perri; Katia De Nadai; Elia Bonomo Roversi; Paola Franceschelli; Adolfo Sebastiani; Michele Rubini
Journal:  Mediators Inflamm       Date:  2013-11-27       Impact factor: 4.711

Review 9.  Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy.

Authors:  Jan M Keppel Hesselink; Ciro Costagliola; Josiane Fakhry; David J Kopsky
Journal:  J Ophthalmol       Date:  2015-11-18       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.